🔎 Trials Near Me

Utama › Artritis Psoriatik › Georgia

Kajian klinikal Artritis Psoriatik di Georgia

7 kajian untuk Artritis Psoriatik sedang mencari peserta di lokasi di Georgia.

Teks kajian rasmi (Bahasa Inggeris)

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  • Emory University, Atlanta
  • Children's Center for Digestive Healthcare, Atlanta
Mengambil pesertaFasa 3
Umur 3 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06663332

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  • Atlanta Research Center for Rheumatology, Marietta
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07321873

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  • Marietta Rheumatology Associates, Marietta
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06671483

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  • Clinical Site, Gainesville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06641089

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

  • North Georgia Rheumatology Group PC, Lawrenceville
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06671496

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  • Emory Children's Center, Atlanta
  • Georgia Regents University Medical Center, Augusta
Mengambil pesertaKajian pemerhatian
Sehingga umur 21 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT02418442

Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

  • Parris and Associates, Lilburn
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 9 Okt 2025 · NCT05669833

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.